Preliminary report on the effect of distigmine bromide on the neurogenic bladder.
D000284:Administration, Oral; D002219:Carbamates / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D009046:Motor Neurons; D010264:Paraplegia / Q000188:drug therapy; D011726:Pyridinium Compounds / Q000627:therapeutic use*; D011782:Quadriplegia / Q000188:drug therapy; D012018:Reflex; D013035:Spasm / Q000150:complications; D001743:Urinary Bladder / Q000000981:diagnostic imaging; D001748:Urinary Bladder Neck Obstruction / Q000209:etiology; D001750:Urinary Bladder, Neurogenic / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D014556:Urine; D014567:Urography
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D011726:Pyridinium Compounds